Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B, Porta, C, Schmidinger, M, Rioux-Leclercq, N, Bex, A, Khoo, V, Grünwald, V, Gillessen, S, Horwich, A
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B, Porta, C, Schmidinger, M, Rioux-Leclercq, N, Bex, A, Khoo, V, Gruenvald, V, Horwich, A
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
Powles, T., Albiges, L., Bex, A., Grünwald, V., Porta, C., Procopio, G., Schmidinger, M., Suárez, C., de Velasco, G.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B, Porta, C, Schmidinger, M, Algaba, F, Patard, J J, Khoo, V, Eisen, T, Horwich, A
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Choueiri, T.K., Motzer, R.J., Rini, B.I., Haanen, J., Campbell, M.T., Venugopal, B., Kollmannsberger, C., Gravis-Mescam, G., Uemura, M., Lee, J.L., Grimm, M.-O., Gurney, H., Schmidinger, M., Larkin, J., Atkins, M.B., Pal, S.K., Wang, J., Mariani, M., Krishnaswami, S., Cislo, P., Chudnovsky, A., Fowst, C., Huang, B., di Pietro, A., Albiges, L.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Powles, T., Albiges, L., Bex, A., Comperat, E., Grünwald, V., Kanesvaran, R., Kitamura, H., McKay, R., Porta, C., Procopio, G., Schmidinger, M., Suarez, C., Teoh, J., de Velasco, G., Young, M., Gillessen, S.
Published in Annals of oncology (01.08.2024)
Published in Annals of oncology (01.08.2024)
Get full text
Journal Article
Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
Haanen, J.B.A.G., Larkin, J., Choueiri, T.K., Albiges, L., Rini, B.I., Atkins, M.B., Schmidinger, M., Penkov, K., Michelon, E., Wang, J., Mariani, M., di Pietro, A., Motzer, R.J.
Published in ESMO open (01.06.2023)
Published in ESMO open (01.06.2023)
Get full text
Journal Article
JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)
Motzer, R.J., Penkov, K., Haanen, J.B.A.G., Rini, B.I., Albiges, L., Campbell, M.T., Kollmannsberger, C.K., Negrier, S., Uemura, M., Lee, J.L., Gurney, H., Berger, R., Schmidinger, M., Larkin, J., Atkins, M.B., Wang, J., Robbins, P.B., Chudnovsky, A., Di Pietro, A., Choueiri, T.K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101
Tomita, Y., Motzer, R.J., Choueiri, T.K., Rini, B.I., Miyake, H., Uemura, H., Albiges, L., Fujii, Y., Umeyama, Y., Wang, J., Mariani, M., Schmidinger, M.
Published in ESMO open (01.04.2022)
Published in ESMO open (01.04.2022)
Get full text
Journal Article
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
VOGL, U. M, ZEHETGRUBER, H, DOMINKUS, M, HEJNA, M, ZIELINSKI, C. C, HAITEL, A, SCHMIDINGER, M
Published in British journal of cancer (18.09.2006)
Published in British journal of cancer (18.09.2006)
Get full text
Journal Article
First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts
Aeppli, S., Schmaus, M., Eisen, T., Escudier, B., Grünwald, V., Larkin, J., McDermott, D., Oldenburg, J., Porta, C., Rini, B.I., Schmidinger, M., Sternberg, C.N., Rothermundt, C., Putora, P.M.
Published in ESMO open (01.02.2021)
Published in ESMO open (01.02.2021)
Get full text
Journal Article
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
Resch, I., Bruchbacher, A., Franke, J., Fajkovic, H., Remzi, M., Shariat, S.F., Schmidinger, M.
Published in ESMO open (01.08.2021)
Published in ESMO open (01.08.2021)
Get full text
Journal Article
Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)
Procopio, G., Bamias, A., Schmidinger, M., Hawkins, R., Rodriguez Sanchez, A., Vazquez, S., Srihari, N., Kalofonos, H., Bono, P., Pisal, C., Hirschberg, Y., Dezzani, L., Ahmad, Q., Suarez Rodriguez, C., Jonasch, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
Tomita, Y., Motzer, R.J., Choueiri, T.K., Rini, B.I., Miyake, H., Oya, M., Albiges, L., Aizawa, M., Umeyama, Y., Wang, J., di Pietro, A., Schmidinger, M.
Published in ESMO open (01.12.2023)
Published in ESMO open (01.12.2023)
Get full text
Journal Article
Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
Steindl, A., Alpar, D., Heller, G., Mair, M.J., Gatterbauer, B., Dieckmann, K., Widhalm, G., Hainfellner, J.A., Schmidinger, M., Bock, C., Müllauer, L., Preusser, M., Berghoff, A.S.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma
Kanesvaran, R., Porta, C., Wong, A., Powles, T., Ng, Q.S., Schmidinger, M., Ye, D., Malhotra, H., Miura, Y., Lee, J.L., Chong, F.L.T., Pu, Y.-S., Yen, C.-C., Saad, M., Lee, H.J., Kitamura, H., Bhattacharyya, G.S., Curigliano, G., Poon, E., Choo, S.P., Peters, S., Lim, E., Yoshino, T., Pentheroudakis, G.
Published in ESMO open (01.12.2021)
Published in ESMO open (01.12.2021)
Get full text
Journal Article
Second-line treatment for metastatic clear cell renal cell cancer: experts’ consensus algorithms
Rothermundt, C., von Rappard, J., Eisen, T., Escudier, B., Grünwald, V., Larkin, J., McDermott, D., Oldenburg, J., Porta, C., Rini, B., Schmidinger, M., Sternberg, C. N., Putora, P. M.
Published in World journal of urology (01.04.2017)
Published in World journal of urology (01.04.2017)
Get full text
Journal Article